CAJ | 학술논문

胰腺癌是消化系统常见的高度恶性肿瘤，起病隐匿、进展迅速、病程极短，预后不良。化疗是晚期胰腺癌患者不可或缺的重要治疗手段。多年来，吉西他滨是其唯一的金标准药物，但疗效有限。白蛋白结合型紫杉醇以其独特的剂型优势，治疗晚期胰腺癌取得了突破性进展，已经成为新的优选药物。
이선암시소화계통상견적고도악성종류，기병은닉、진전신속、병정겁단，예후불량。화료시만기이선암환자불가혹결적중요치료수단。다년래，길서타빈시기유일적금표준약물，단료효유한。백단백결합형자삼순이기독특적제형우세，치료만기이선암취득료돌파성진전，이경성위신적우선약물。
Pancreatic carcinoma( PC) is one of the most detrimental common digestive malignancies, which is characterized by hidden onset, rapid progression and short course. Chemotherapy is an indispensable treatment approaches for patients with advanced PC. Gemcitabine act as a gold standard drug, but its effect is limited. A new drug, that is Nab-paclitaxel with its unique formulation advantage, has made breakthrough progress in the treatment of advanced PC and has become the new standard chemotherapy drugs for advanced pancreatic carcinoma.